Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BRAUN, Joséphine")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 10 of 10

  • Page / 1
Export

Selection :

  • and

A cell line-based bioassay of non β-chemokine-related HIV suppressive activityBRAUN, Joséphine; BERETTA, Alberto.AIDS (London). 2000, Vol 14, Num 18, pp 2940-2941, issn 0269-9370Article

Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West AfricaLOMBART, Jean Pierre; VRAY, Muriel; KAFANDO, Anatole et al.AIDS (London). 2005, Vol 19, Num 12, pp 1273-1277, issn 0269-9370, 5 p.Article

High Concentration of Raltegravir in Semen of HIV-Infected Men: Results from a Substudy of the EASIER-ANRS 138 TrialBARAU, Caroline; DELAUGERRE, Constance; BRAUN, Joséphine et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 2, pp 937-939, issn 0066-4804, 3 p.Article

A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypesBRAUN, Joséphine; PLANTIER, Jean-Christophe; HELLOT, Marie-France et al.AIDS (London). 2003, Vol 17, Num 3, pp 331-336, issn 0269-9370, 6 p.Article

Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremiaGALLIEN, Sébastien; DELAUGERRE, Constance; CHARREAU, Isabelle et al.AIDS (London). 2011, Vol 25, Num 5, pp 665-669, issn 0269-9370, 5 p.Article

Differences in proviral DNA load between HIV-1-and HIV-2-infected patientsGUEUDIN, Marie; DAMOND, Florence; BRAUN, Joséphine et al.AIDS (London). 2008, Vol 22, Num 2, pp 211-215, issn 0269-9370, 5 p.Article

Phenotypic susceptibility to nonnucleoside inhibitors of virion-associated reverse transcriptase from different HIV types and groupsTUAILLON, Edouard; GUEUDIN, Marie; LEMEE, Véronique et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 37, Num 5, pp 1543-1549, issn 1525-4135, 7 p.Article

Decreases in Inflammatory and Coagulation Biomarkers Levels in HIV-Infected Patients Switching from Enfuvirtide to Raltegravir: ANRS 138 SubstudySILVA, Erika F; CHARREAU, Isabelle; GOURME, Bernard et al.The Journal of infectious diseases. 2013, Vol 208, Num 6, pp 892-897, issn 0022-1899, 6 p.Article

Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimenDELAUGERRE, Constance; CHARREAU, Isabelle; BRAUN, Josephine et al.AIDS (London). 2010, Vol 24, Num 15, pp 2391-2395, issn 0269-9370, 5 p.Article

Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trialGALLIEN, Sébastien; BRAUN, Josephine; ABOULKER, Jean-Pierre et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 9, pp 2099-2106, issn 0305-7453, 8 p.Article

  • Page / 1